Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,498 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial Comment.
Sahu KK, Agarwal N. Sahu KK, et al. Among authors: agarwal n. J Urol. 2023 Jan;209(1):130. doi: 10.1097/JU.0000000000002969.01. Epub 2023 Jan 1. J Urol. 2023. PMID: 36484444 No abstract available.
Editorial Comment.
Swami U, Agarwal N. Swami U, et al. Among authors: agarwal n. J Urol. 2021 Dec;206(6):1429. doi: 10.1097/JU.0000000000002121.01. Epub 2021 Aug 30. J Urol. 2021. PMID: 34455827 No abstract available.
Survival of Patients with Metastatic Prostate Cancer After Disease Progression on an Androgen Receptor Axis-Targeted Therapy Given in the Metastatic Castration-Sensitive Versus Metastatic Castration-Resistant Prostate Cancer Setting.
Sayegh N, Tripathi N, Nussenzveig RH, Thomas VM, Tandar C, Goel D, Nordblad B, Sahu KK, Li H, L Maughan B, Agarwal N, Swami U. Sayegh N, et al. Among authors: agarwal n. Eur Urol Focus. 2023 Jan;9(1):106-109. doi: 10.1016/j.euf.2022.06.015. Epub 2022 Jul 11. Eur Urol Focus. 2023. PMID: 35835693
Relugolix in the management of prostate cancer.
Sahu KK, Tripathi N, Agarwal N, Swami U. Sahu KK, et al. Among authors: agarwal n. Expert Rev Anticancer Ther. 2022 Sep;22(9):891-902. doi: 10.1080/14737140.2022.2105209. Epub 2022 Jul 27. Expert Rev Anticancer Ther. 2022. PMID: 35866612 Review.
Impact of Initial Timing of Metastatic Disease on Survival in Patients With Newly Diagnosed Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Pathway Inhibitors.
Gebrael G, Sayegh N, Tripathi N, Goel D, McFarland T, Ebrahimi H, Nordblad B, Chigarira B, Mathew Thomas V, Sahu KK, Li H, Chehrazi-Raffle A, Kohli M, Agarwal N, Swami U, Maughan BL. Gebrael G, et al. Among authors: agarwal n. Urol Pract. 2024 Jan;11(1):32-35. doi: 10.1097/UPJ.0000000000000471. Epub 2023 Oct 30. Urol Pract. 2024. PMID: 37903742
2,498 results